Episode 422: ACSO 2025 - ctDNA Data From NIAGARA

By The Uromigos - Last Updated: June 2, 2025

Dr. Matt Galsky discusses the 2025 ASCO Annual Meeting data regarding ctDNA from the NIAGARA neoadjuvant chemo +/- durvalumab study.

Post Tags:Uromigos-ASCO

Related Podcasts

Episode 432: ASCO 2025 Rapid Oral Session RCC/Bladder Recap
Uromigos-Bladder Cancer
Episode 431: IMPACT Series - Axel Bex on Impactful RCC Clinical Trials
Uromigos-Kidney Cancer
Episode 430: Structured Exercise Improves DFS/OS After Adjuvant Therapy in Colorectal Cancer - Does This Apply to GU Cancers?
Episode 428: ASCO 2025 Recap
Episode 427: Emerging Data in Non-Muscle Invasive Bladder Cancer
Uromigos-Bladder Cancer
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.

    Terms of Use | Privacy Policy |